Public Reporting

ACO Name and Location
Missouri Health Plus, LLC
7777 Bonhomme Ave. Suite 2300
Clayton, MO 63105
ACO Primary Contact
Danny O’Neill- Chief Executive Officer
Email: doneill@missourihealthplus.com
Phone: 314-786-3330

 

Organizational Information

ACO Participants

No Participants are involved in a joint venture between ACO professionals and hospitals

ACO Governing Body

  • Jeff Davis, Voting Member of ACO Board, ACO Participant (Community Health Center of Central Missouri)
  • Don McBride, Vice Chairman and Voting Member of ACO Board, ACO Participant (Access Family Care)
  • Angela Clabon, Voting Member of ACO Board, ACO Participant (Myrtle H. Davis Comprehensive Health Centers)
  • Bob Massie, Voting Member of ACO Board, Community Stakeholder
  • Brooks Miller, Voting Member of ACO Board, ACO Participant (Jordan Valley)
  • Dave Barber, Voting Member of ACO Board, ACO Participant (Swope Health Services)
  • Ron Camp, Voting Member of ACO Board, ACO Participant (Cross Trails Medical Center)

Key Clinical and Administrative Leadership

  • Danny O’Neill, Chief Executive Officer
  • Susan Wilson, Director of Population Health
  • Dr. Crystal Sullivan, Chief Medical Officer

Committees and Committee Leadership

  • Medicare Beneficiary Engagement Committee
    • Karen Lumley, Chairwoman, Medicare Beneficiary, ACO Participant (Family Health Center and Northeast Missouri Health Council)
    • Gloria Crull, Vice Chairwoman, Medicare Beneficiary, ACO Board, ACO Participant (Family Health Center)
    • Al Chapman, Committee Member, Medicare Beneficiary, ACO Participant (Access Family Care)
    • Flora McCallister, Committee Member, Medicaid Beneficiary, ACO Participant (Family Health Center)
    • Don McBride, Committee Member, Voting Member of ACO Board, ACO Participant (Access Family Care)
  • Clinical Quality Committee- Brooks Miller, Chair
  • Contracts Committee- Dave Barber, Chair
  • Finance Committee- Ron Camp, Chair
  • Standards & Compliance Committee- Bob Massie, Chair

Types of ACO Participants, or combination of Participants, that formed the ACO

  • The MissouriHealth+ ACO is comprised of a network of 19 FQHCs

Amount of Shared Savings and Losses

  • First Agreement Period
    • Performance Year 2016: $0

Shared Savings Distribution:

  • First Agreement Period
    • Performance Year 2016: $0
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Quality Performance Results

  • 2016 Quality Performance Results:
ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 77.91 79.9
ACO-2 CAHPS: How Well Your Providers Communicate 90.88 92.63
ACO-3 CAHPS: Patients’ Rating of Provider 89.53 91.93
ACO-4 CAHPS: Access to Specialists 81.74 83.52
ACO-5 CAHPS: Health Promotion and Education 64.19 60
ACO-6 CAHPS: Shared Decision Making 74.09 75.28
ACO-7 CAHPS: Health Status/Functional Status 72.95 71.82
ACO-34 CAHPS: Stewardship of Patient Resources 33.34 27.52
ACO-8 Risk-Standardized, All Condition Readmission 14.64 14.7
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM) 17.61 18.17
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 49 53.2
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 66.76 75.23
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 57.96 59.81
ACO-9 Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 6.5 9.27
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 ) 12.21 14.53
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements 60.71 82.72
ACO-39 Documentation of Current Medications in the Medical Record 67.22 87.54
ACO-13 Falls: Screening for Future Fall Risk 19.97 64.04
ACO-14 Preventive Care and Screening: Influenza Immunization 37.27 68.32
ACO-15 Pneumonia Vaccination Status for Older Adults 58.35 69.21
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up 75.04 74.45
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 80.65 90.98
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 65.87 53.63
ACO-19 Colorectal Cancer Screening 48.49 61.52
ACO-20 Breast Cancer Screening 45.53 67.61
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented 68.13 76.84
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 68.81 77.72
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 22.06 18.24
ACO-41 Diabetes: Eye Exam 27.21 44.94
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 63.88 70.52
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 56.16 85.05
ACO-31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 94.12 88.67
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF) 81.38 79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

  • For 2016 Quality Performance Results please click here

Payment Rule Waivers

  • Our ACO does not use the SNF 3-Day Rule Waiver.